Cargando…

Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401

An increase in the peripheral synthesis of serotonin and kynurenine, observed during the chronic kidney disease (CKD) course, is negatively associated with bone health. Serotonin and kynurenine are connected by the common precursor, tryptophan. LP533401 is an inhibitor of peripheral serotonin synthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mor, Adrian, Pawlak, Krystyna, Kalaska, Bartlomiej, Domaniewski, Tomasz, Sieklucka, Beata, Zieminska, Marta, Cylwik, Bogdan, Pawlak, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503245/ https://www.ncbi.nlm.nih.gov/pubmed/32825192 http://dx.doi.org/10.3390/ijms21175979

Ejemplares similares

Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling
por: Pawlak, Krystyna, et al.
Publicado: (2021)

Vitamin K-Dependent Carboxylation of Osteocalcin in Bone—Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease?
por: Ziemińska, Marta, et al.
Publicado: (2022)

A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease—Apart or Together?
por: Ziemińska, Marta, et al.
Publicado: (2021)

Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
por: Mor, Adrian, et al.
Publicado: (2020)

The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
por: Pawlak, Dariusz, et al.
Publicado: (2016)

Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
por: Karbowska, Malgorzata, et al.
Publicado: (2018)

MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Monitoring of Cardiorespiratory Parameters in Rats—Validation Based on Pharmacological Stimulation
por: Miklosz, Joanna, et al.
Publicado: (2021)

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
por: Kim, Kyoung Min, et al.
Publicado: (2017)

The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats
por: Kalaska, Bartlomiej, et al.
Publicado: (2022)

The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2019)

Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
por: Tankiewicz‐Kwedlo, Anna, et al.
Publicado: (2018)

The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target
por: Kalaska, Bartlomiej, et al.
Publicado: (2019)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice
por: Swieton, Justyna, et al.
Publicado: (2021)

Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice
por: Goto, Tadashi, et al.
Publicado: (2014)

Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
por: Kalaska, Bartlomiej, et al.
Publicado: (2015)

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
por: Miklosz, Joanna, et al.
Publicado: (2019)

Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer
por: Rozkiewicz, Dariusz, et al.
Publicado: (2020)

Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin—A New Potential Link in the Pathogenesis of Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models
por: Miklosz, Joanna, et al.
Publicado: (2021)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
por: Mahoney, David J., et al.
Publicado: (2008)

A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis
por: Yogui, Fernanda Costa, et al.
Publicado: (2018)

The extracellular matrix of human bone marrow adipocytes and glucose concentration differentially alter mineralization quality without impairing osteoblastogenesis
por: Entz, Laura, et al.
Publicado: (2022)

LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease
por: Brunetti, Giacomina, et al.
Publicado: (2014)

TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation
por: Rahman, Md Shaifur, et al.
Publicado: (2015)

Activated B Lymphocyte Inhibited the Osteoblastogenesis of Bone Mesenchymal Stem Cells by Notch Signaling
por: Pan, Mengxue, et al.
Publicado: (2019)

Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis
por: Yang, Jihyun, et al.
Publicado: (2019)

Cell trafficking and regulation of osteoblastogenesis by extracellular vesicle associated bone morphogenetic protein 2
por: Yerneni, Saigopalakrishna S., et al.
Publicado: (2021)

UBAP2 plays a role in bone homeostasis through the regulation of osteoblastogenesis and osteoclastogenesis
por: Kim, Jeonghyun, et al.
Publicado: (2023)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
por: Baran, Anna, et al.
Publicado: (2022)

Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1lrcnk76k3v77g68n58ajqf414